Indian drug giant Dr Reddy's Q2 profit up 69%

India's second-largest drugmaker Dr Reddy's Laboratories on Tuesday reported a 69.4 percent jump in quarterly net profit, as profit margins rose helped by improved sales.

Dr Reddy's consolidated rose to 6.90 billion rupees ($112 million) for the three months to September, from 4.07 billion rupees a year earlier.

The company, also listed on the New York Stock Exchange, said total revenues rose 17 percent to 33.6 billion rupees, as North American sales surged 43 percent while Russian revenues jumped 44 percent.

The company's gross profit margin rose to 28.3 percent compared to 25.9 percent in the same period last year.

During the quarter, the Hyderabad-based firm launched 19 new generic products and filed 13 new product registrations.

add to favorites email to friend print save as pdf

Related Stories

India's Wipro Q2 profit up 29%, beats forecasts

Oct 22, 2013

India's third-largest software firm Wipro on Tuesday reported quarterly net profit climbed 29 percent year-on-year, led by a jump in outsourcing orders as global business conditions improved.

India's Wipro shares tumble as revenue lags

Oct 23, 2013

Shares in India's third largest IT outsourcer Wipro slumped more than eight percent on Wednesday, a day after it announced modest revenue growth that lagged rivals, analysts said.

India's HCL profit jumps 43%, shares gain

Jan 17, 2012

India's fourth-biggest software services firm, HCL, Tuesday posted a 43 percent jump in quarterly net profit, beating forecasts, thanks to stronger outsourcing demand and a weak rupee.

Recommended for you

Face transplants change lives, identity

23 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

User comments